Kissei Pharmaceutical Co., Ltd. (TYO: 4547)
Japan
· Delayed Price · Currency is JPY 3,445.00
-65.00 (-1.85%)
Dec 20, 2024, 3:45 PM JST
Kissei Pharmaceutical Cash Flow Statement
Financials in millions JPY. Fiscal year is April - March.
Millions JPY. Fiscal year is Apr - Mar.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2015 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '24 Sep 30, 2024 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 | Mar '20 Mar 31, 2020 | 2019 - 2015 |
| Net Income | 14,106 | 14,449 | 13,680 | 16,507 | 7,476 | 4,630 | Upgrade
|
| Depreciation & Amortization | 4,487 | 4,254 | 4,109 | 3,730 | 3,148 | 2,562 | Upgrade
|
| Loss (Gain) From Sale of Assets | 184 | -80 | -63 | 35 | 10 | 35 | Upgrade
|
| Loss (Gain) From Sale of Investments | -9,406 | -9,119 | -13,133 | -16,161 | -4,727 | -1,433 | Upgrade
|
| Other Operating Activities | -3,862 | -1,893 | -5,799 | -2,672 | -769 | -1,164 | Upgrade
|
| Change in Accounts Receivable | -333 | -5,863 | 27 | 250 | -3,595 | 7,500 | Upgrade
|
| Change in Inventory | -1,711 | -3,480 | -3,810 | 1,130 | -6,679 | 525 | Upgrade
|
| Change in Accounts Payable | 537 | 275 | 513 | -3,804 | 2,671 | 890 | Upgrade
|
| Change in Other Net Operating Assets | -571 | -220 | -2,203 | 2,518 | -77 | 389 | Upgrade
|
| Operating Cash Flow | 3,431 | -1,677 | -6,679 | 1,533 | -2,542 | 13,934 | Upgrade
|
| Operating Cash Flow Growth | - | - | - | - | - | 119.57% | Upgrade
|
| Capital Expenditures | -2,641 | -1,201 | -2,103 | -1,489 | -931 | -879 | Upgrade
|
| Sale of Property, Plant & Equipment | 130 | 175 | 78 | 23 | 3 | 70 | Upgrade
|
| Sale (Purchase) of Intangibles | -499 | -632 | -444 | -430 | -554 | -423 | Upgrade
|
| Investment in Securities | 10,386 | 9,502 | 13,031 | 16,391 | 790 | 2,067 | Upgrade
|
| Other Investing Activities | 437 | 844 | -4,564 | -3,741 | -8,669 | -437 | Upgrade
|
| Investing Cash Flow | 7,816 | 8,690 | 6,001 | 10,776 | -9,329 | 490 | Upgrade
|
| Total Debt Issued | 150 | - | - | - | - | - | Upgrade
|
| Short-Term Debt Repaid | - | -150 | -150 | -90 | - | - | Upgrade
|
| Long-Term Debt Repaid | - | - | - | -13 | -16 | -1,934 | Upgrade
|
| Total Debt Repaid | -280 | -150 | -150 | -103 | -16 | -1,934 | Upgrade
|
| Net Debt Issued (Repaid) | -130 | -150 | -150 | -103 | -16 | -1,934 | Upgrade
|
| Repurchase of Common Stock | -5,051 | -6,000 | - | - | -1,303 | - | Upgrade
|
| Dividends Paid | -3,690 | -3,722 | -3,135 | -2,536 | -2,475 | -2,382 | Upgrade
|
| Other Financing Activities | -136 | -134 | -135 | -117 | -206 | -103 | Upgrade
|
| Financing Cash Flow | -9,007 | -10,006 | -3,420 | -2,756 | -4,000 | -4,419 | Upgrade
|
| Foreign Exchange Rate Adjustments | -48 | -3 | -21 | 4 | - | - | Upgrade
|
| Miscellaneous Cash Flow Adjustments | -4 | -1 | -1 | - | -1 | -1 | Upgrade
|
| Net Cash Flow | 2,188 | -2,997 | -4,120 | 9,557 | -15,872 | 10,004 | Upgrade
|
| Free Cash Flow | 790 | -2,878 | -8,782 | 44 | -3,473 | 13,055 | Upgrade
|
| Free Cash Flow Growth | - | - | - | - | - | 148.52% | Upgrade
|
| Free Cash Flow Margin | 0.97% | -3.81% | -13.01% | 0.07% | -5.03% | 20.65% | Upgrade
|
| Free Cash Flow Per Share | 17.79 | -63.59 | -190.44 | 0.95 | -74.42 | 279.45 | Upgrade
|
| Cash Interest Paid | 19 | 18 | 20 | 23 | 23 | 23 | Upgrade
|
| Cash Income Tax Paid | 3,820 | 1,834 | 5,699 | 2,567 | 652 | 1,048 | Upgrade
|
| Levered Free Cash Flow | 7,800 | 200.38 | -7,654 | 3,843 | -7,691 | 15,059 | Upgrade
|
| Unlevered Free Cash Flow | 7,811 | 211.63 | -7,641 | 3,858 | -7,677 | 15,074 | Upgrade
|
| Change in Net Working Capital | -4,100 | 4,720 | 8,489 | -2,923 | 10,281 | -12,653 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.